The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)

Margriet Oosterveld, Stefan Suciu, G. Verhoef, Boris Labar, Amine Belhabri, Carlo Aul, Dominik Selleslag, Augustin Ferrant, P. W. Wijermans, Franco Mandelli,

Leukemia · 2003 · 46 citations · 31 references

Concepts

References

31